This inventor holds 11 USPTO granted patents. Top assignee: Banyu Pharmaceutical Co. Ltd. Active years: 1997-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-2000
Title: Kumiko Kawakami: Innovator in Pharmaceutical Chemistry
Introduction
Kumiko Kawakami is a prominent inventor based in Tsukuba, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target muscarinic receptors. With a total of 11 patents to her name, her work has the potential to impact various medical treatments.
Latest Patents
One of her latest patents involves N-acyl cyclic amine derivatives. This invention relates to compounds represented by a specific general formula, where the compounds exhibit potent selective antagonistic activity against muscarinic M3 receptors. These compounds are noted for their excellent oral activity, durability of action, and favorable pharmacokinetics. They are considered very useful as safe and effective remedies against respiratory, urinary, and digestive diseases, with minimal adverse side effects. Another area of her research includes substituted amide derivatives, further showcasing her innovative approach to pharmaceutical development.
Career Highlights
Kumiko Kawakami is associated with Banyu Pharmaceutical Co. Ltd., where she has been instrumental in advancing research and development in her field. Her work has not only contributed to the company's portfolio but has also enhanced the understanding of drug interactions and efficacy.
Collaborations
Throughout her career, Kawakami has collaborated with notable colleagues such as Yoshikazu Iwasawa and Tetsuya Aoyama. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Kumiko Kawakami's contributions to pharmaceutical chemistry are noteworthy, with her innovative patents paving the way for new treatments. Her dedication to research and collaboration continues to influence the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile